Essentra (LON:ESNT) Shares Cross Below Two Hundred Day Moving Average – Here’s Why

Essentra plc (LON:ESNTGet Free Report) shares crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 102.07 and traded as low as GBX 96.50. Essentra shares last traded at GBX 96.60, with a volume of 163,390 shares.

Analyst Ratings Changes

ESNT has been the topic of a number of recent research reports. Berenberg Bank reduced their price objective on shares of Essentra from GBX 170 to GBX 160 and set a “buy” rating on the stock in a research note on Thursday, October 30th. Jefferies Financial Group cut their price target on Essentra from GBX 170 to GBX 150 and set a “buy” rating on the stock in a research note on Monday, November 10th. Four analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of GBX 178.75.

Check Out Our Latest Report on ESNT

Essentra Stock Down 0.6%

The company has a current ratio of 1.97, a quick ratio of 0.50 and a debt-to-equity ratio of 51.89. The firm’s fifty day moving average price is GBX 97.77 and its 200-day moving average price is GBX 102.07. The company has a market cap of £275.48 million, a price-to-earnings ratio of 29.27, a price-to-earnings-growth ratio of 3.84 and a beta of 1.18.

Essentra Company Profile

(Get Free Report)

Essentra plc is a leading global provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items.

Headquartered in the United Kingdom, Essentra’s global network extends to 28 countries worldwide and includes c.3,000 employees, 14 manufacturing facilities, 26 distribution centres and 37 sales & service centres serving c.64,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy.

See Also

Receive News & Ratings for Essentra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Essentra and related companies with MarketBeat.com's FREE daily email newsletter.